Hsu J, Donahue R, Katragadda M, Lowry J, Huang W, Srinivasan K
Sci Transl Med. 2023; 15(724):eadi0258.
PMID: 38019931
PMC: 11421222.
DOI: 10.1126/scitranslmed.adi0258.
Chen K, Jenkins E, Korbel M, Ponjavic A, Lippert A, Santos A
Proc Natl Acad Sci U S A. 2021; 118(39).
PMID: 34526387
PMC: 8488633.
DOI: 10.1073/pnas.2024250118.
Liu Y, Jurczak M, Lear T, Lin B, Larsen M, Kennerdell J
Nat Chem Biol. 2021; 17(3):298-306.
PMID: 33495648
PMC: 8529588.
DOI: 10.1038/s41589-020-00723-0.
Juraske C, Wipa P, Morath A, Villacorta Hidalgo J, Hartl F, Raute K
Front Immunol. 2018; 9:1579.
PMID: 30038626
PMC: 6046647.
DOI: 10.3389/fimmu.2018.01579.
Weiss A, Stobo J
Front Immunol. 2015; 6:163.
PMID: 25954271
PMC: 4404948.
DOI: 10.3389/fimmu.2015.00163.
The birth pangs of monoclonal antibody therapeutics: the failure and legacy of Centoxin.
Marks L
MAbs. 2012; 4(3):403-12.
PMID: 22531443
PMC: 3355486.
DOI: 10.4161/mabs.19909.
Co-engagement of alpha(4)beta(1) integrin (VLA-4) and CD4 or CD8 is necessary to induce maximal Erk1/2 phosphorylation and cytokine production in human T cells.
Kim T, Billard M, Wieder E, McIntyre B, Komanduri K
Hum Immunol. 2009; 71(1):23-8.
PMID: 19815047
PMC: 2795106.
DOI: 10.1016/j.humimm.2009.09.360.
Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice.
Ohira M, Ishiyama K, Tanaka Y, Doskali M, Igarashi Y, Tashiro H
J Clin Invest. 2009; 119(11):3226-35.
PMID: 19805910
PMC: 2769186.
DOI: 10.1172/JCI38374.
Prevention of transplant rejection: current treatment guidelines and future developments.
Perico N, Remuzzi G
Drugs. 1997; 54(4):533-70.
PMID: 9339960
DOI: 10.2165/00003495-199754040-00003.
Effects of anti-CD3 monoclonal antibodies on functional activity of lymphocytes: studies in vivo and in vitro.
Parlevliet K, Chamuleau M, Yong S, Raasveld M, ten Berge I, Schellekens P
Clin Exp Immunol. 1995; 99(2):155-9.
PMID: 7851005
PMC: 1534302.
DOI: 10.1111/j.1365-2249.1995.tb05526.x.
Activation via TCR or IL-2 receptor of a CD8+ suppressor T cell clone: effect on IL-10 production and on proliferation of the suppressor T cell.
Minai Y, Hisatsune T, Nishijima K, Enomoto A, Kaminogawa S
Cytotechnology. 1994; 14(2):81-7.
PMID: 7765241
DOI: 10.1007/BF00758172.
Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.
Sanchez-Madrid F, Krensky A, Ware C, Robbins E, Strominger J, Burakoff S
Proc Natl Acad Sci U S A. 1982; 79(23):7489-93.
PMID: 6984191
PMC: 347365.
DOI: 10.1073/pnas.79.23.7489.
Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens.
Biddison W, Rao P, Talle M, Goldstein G, Shaw S
J Exp Med. 1982; 156(4):1065-76.
PMID: 6984061
PMC: 2186824.
DOI: 10.1084/jem.156.4.1065.
Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies.
Landegren U, Ramstedt U, Axberg I, Ullberg M, Jondal M, Wigzell H
J Exp Med. 1982; 155(5):1579-84.
PMID: 6978378
PMC: 2186685.
DOI: 10.1084/jem.155.5.1579.
Human natural killer cells, activated lymphocyte killer cells, and monocytes possess similar cytotoxic mechanisms.
Burns G, Triglia T, Bartlett P, Mackay I
Proc Natl Acad Sci U S A. 1983; 80(24):7606-10.
PMID: 6608725
PMC: 534389.
DOI: 10.1073/pnas.80.24.7606.
Detection of antilymphocyte antibodies in patients with scleroderma using three different techniques.
Labro M, Perianin A, Kahn M
Clin Rheumatol. 1984; 3(4):435-41.
PMID: 6441668
DOI: 10.1007/BF02031265.
Regulation of T-cell function by antibodies: enhancement of the response of human T-cell clones to hepatitis B surface antigen by antigen-specific monoclonal antibodies.
Celis E, Zurawski Jr V, Chang T
Proc Natl Acad Sci U S A. 1984; 81(21):6846-50.
PMID: 6436821
PMC: 392029.
DOI: 10.1073/pnas.81.21.6846.
Ethnic differences in the lymphocyte proliferative response induced by a murine IgG1 antibody, Leu-4, to the T3 molecule.
AboT , Tilden A, Balch C, Kumagai K, TROUP G, Cooper M
J Exp Med. 1984; 160(1):303-9.
PMID: 6429266
PMC: 2187429.
DOI: 10.1084/jem.160.1.303.
Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function.
Moretta A, Pantaleo G, Mingari M, Moretta L, Cerottini J
J Exp Med. 1984; 159(3):921-34.
PMID: 6421984
PMC: 2187241.
DOI: 10.1084/jem.159.3.921.
Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
Suthanthiran M, Williams P, Solomon S, RUBIN A, STENZEL K
J Clin Invest. 1984; 74(6):2263-71.
PMID: 6392343
PMC: 425419.
DOI: 10.1172/JCI111653.